News
Pediatric bronchiolitis: Less is more
April 27, 2021
With bronchiolitis still the poster disease for low-value interventions, it’s time to retire widely used but ineffective therapies and focus on supportive care, researchers say.
News
Trend reversed: New cases of COVID-19 decline in children
April 27, 2021
Children’s share of weekly cases continues to rise, setting another pandemic high.
News
Thyroid hormone analogues can reverse NASH
April 27, 2021
In patients with nonalcoholic steatohepatitis (NASH) and stages 1-3 fibrosis, does the thyroid hormone receptor beta-agonist, resmetirom reduce hepatic steatosis compared with placebo?
News
Efficacy and safety of daily low-dose colchicine after recent MI
April 26, 2021
Can giving low-dose colchicine to patients after a recent myocardial infarction reduce future ischemic cardiovascular events, compared with placebo?
News
Feds lift pause of J&J COVID vaccine, add new warning
April 23, 2021
The warning is directed at women under the age of 50.
News
Study: COVID-19 can kill months after infection
April 23, 2021
The risk of death is increased up to 6 months after they catch the virus.
News
Can we get to ‘COVID zero’? Experts predict the next 8 months
April 23, 2021
“Right now, we are projecting the United States all the way to Aug. 1 [will have] 619,000 deaths from COVID-19, with 4.7 million globally,” said Ali H. Mokdad, PhD.
News
Lower target LDL-C cuts risk of CV events in ischemic stroke patients
April 23, 2021
Is a target LDL cholesterol (LDL-C) level of less than 70 mg/dL superior to a target LDL-C level of 90-110 mg/dL in prevention of future cardiovascular (CV) events in patients with a prior stroke of atherosclerotic origin or transient ischemic attack (TIA)?
News
COVID-19 infection conveys imperfect immunity in young adults
April 23, 2021
One in 10 Marine recruits with prior SARS-CoV-2 infections were reinfected during basic training.
News
COVID plus MI confers poor prognosis; 1 in 3 die in hospital
April 22, 2021
National registry data confirm the challenges and uniqueness of patients with STEMI and COVID-19, with atypical symptoms and ‘very high’ in-hospital mortality rates.